Company
A new era for human health
GSK is a global biopharma company with the ambition and purpose to unite science, technology and talent to get ahead of disease together.
A signal for change
Scroll to explore
Our strategy
We make innovative vaccines and specialty medicines to prevent and treat disease. Our R&D focuses on the science of the immune system, human genetics and advanced technologies.
Our R&D focus is on four therapeutic areas: infectious diseases, HIV, oncology, and immunology.
Infectious diseases
1 in 3
of us will be affected by shingles in our lifetime
Oncology
~10m
people died from cancer in 2020, making it a leading cause of death worldwide
Behind the science
Discover how we're getting ahead

Unlocking the power of the immune system to get ahead of hepatitis B

Tackling tomorrow’s health challenges today

How vaccine science can help tackle antimicrobial resistance

The 40 year fight against HIV

How the next generation of immuno-oncology could help us get ahead of cancer

1.4 million reasons to get ahead of gynaecologic cancers

Digital twin: using advanced technology to accelerate vaccine development

What if remission were the target of lupus care?

Synthetic Lethality: accelerating precision cancer treatments

Tech for T-cells single cell RNA seq measures shifts in immune cells to pinpoint causes of disease
Outstanding people

INNOVATING TOGETHER 2022
Meet Mugdha: working together to help more patients

WORKING TOGETHER
Meet Tim: valuing neurodiversity in Global Health

WORKING TOGETHER
Meet Fiona: improving health and wellbeing through nature

WORKING TOGETHER
Meet Andy: how a life-changing diagnosis changed his career

THRIVING TOGETHER
Meet Alison: taking pride in working for GSK

INNOVATING TOGETHER 2022
Meet Pal: combining the power of genetics and genomics